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ABSTRACT 
 
Traumatic Brain Injury (TBI) is a widespread, degenerative affliction 
with no current therapeutic interventions. The long-term degradation 
caused by TBI results from secondary injury cascades that are initiated by 
primary injury. An early and important step in the damage process is 
reactive astrogliosis in astrocytes. Astrocytes communicate through gap 
junctions, which are composed of two connexon hemichannels from the 
two communicating cells and these connexons themselves are composed 
of six connexin protein subunits. Connexin 43 (Cx43) is a particularly 
important connexin to gap junctional communication and could act either 
to preserve the astrocytes from oxidative stress, or to propagate the 
damage signals to otherwise healthy cells. The present study investigates 
the expression of Cx43 in different treatment types in hippocampal 
samples of Wistar rats in order to elucidate the relationship between 
Cx43 and secondary injury through Real-Time PCR (qPCR) and cell culture 
work. While Cx43 has a trend for increased expression in traumatized 
tissue that is returned to normal levels with an antioxidant treatment, 
these results are not statistically significant according to a single- sided 
ANOVA test. Further research is needed to understand the relationship 
between Cx43 and secondary injury. 
 
INTRODUCTION 
 
The major health issues responsible for injury and death in the 
United States are typically accompanied by a slew of possible medications 
and therapies available to the patient. However, traumatic brain injury 
(TBI), one of the most significant sources of injury and long-term 
complications occurs in many ways and impacts people in all walks of 
life. Whether from car accidents, military injuries, recreational accidents, 
occupational hazards, professional football or high school basketball, TBI 
is a prominent and pervasive detriment to health and well-being. There 
are approximately one to two million new incidences of moderate TBI 
(mTBI) that are documented in the US annually, not including unreported 
cases (Lovell et al., 2004). Moreover, TBI is a severe affliction throughout 
the globe with an estimated incidence of 200 per 100,000 people 
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annually, although this is most likely a significant underestimate given 
the limitations of a global census (Bryan-Hancock and Harrison, 2011). 
Moreover, the popularity of high school sports makes mTBI a serious 
threat to young people through multiple concussions during athletic 
competition, making young people vulnerable to life-long degenerative 
afflictions as there is no established pharmaceutical intervention or 
effective therapy to allay disease progression. 
TBI is an overarching term describing both the macroscopic and 
microscopic physiological processes that occur in response to brain 
trauma. The initial primary injury is classified in multiple ways based on 
the size of the affected area, whether or not the skull was penetrated, 
and the severity of the injury. There are several scales employed to 
classify the severity of the injury. One diagnostic tool for categorization 
of injury is the Glasgow Coma Scale, which assesses different responses 
and functions of the injured patient and translates the results of these 
various criteria into a numerical score, corresponding to one of three 
possible ranges representing mild, moderate, and severe TBI (Orange 
County Neurology Medical Center, n.d.) Severe head injury typically has a 
Glasgow Coma Scale score less than eight, moderate head injury between 
nine to twelve and mild injury between thirteen and fifteen (Miller, 2013). 
Concussions are typically associated with mild TBI. Other classifications 
of TBI are based on whether or not the damaged tissue is exposed to the 
local environment and also applied. Focal injuries affect one particular 
area, whereas diffuse injuries cause more widespread damage. Open TBI 
refers to injuries in which the skull is penetrated and the wound is 
exposed, whereas closed TBI involves damage to the brain where the 
skull remains intact and the brain tissues remain unexposed and 
separated from the local environment (Heegaard, et al., 2013). 
Primary injury, which occurs at the time the trauma is incurred, is 
considered irreversible; however, the secondary injuries that result from 
the cytotoxic cascades and destructive biochemical events that occur 
within cells could potentially be interrupted, possibly limiting the damage 
typically associated with moderate TBI. The biochemical and cellular 
events that occur following primary TBI and eventually lead to the 
damages associated with secondary TBI are complex and heavily 
researched. Certain events are known to occur following TBI starting with 
massive, widespread neuronal depolarization and eventually leading to 
lipid peroxidation, increase in glial-fibrillary acidic protein (GFAP), 
reactive gliosis, release of excitatory amino acids such as glutamate, 
higher calcium influx into neurons leading to increased generation of 
excitatory postsynaptic potentials (EPSPs), nitric oxide (NO) release, and 
cytotoxicity (Greve, M.W. and B. Zink, 2009). These physiological and 
biochemical changes initiate the accumulation of damage seen in 
secondary injury, causing damage to neurons and glial cells and 
impairing neuronal communication and synaptic transmission, thereby 
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facilitating a decrease in brain function including impaired learning and 
memory formation. Three key facets of secondary injury are increased 
levels of glutamate, free radicals and NO, which constitute a mutually-
amplifying triad, referred to as the tripartite synthesis, perpetuating and 
propagating neuronal damage (Greve, M.W. and B. Zink, 2009). A less 
emphasized result of TBI is the transient increase in gap junctional 
coupling that occurs following trauma (Franseva et al., 2002). 
Gap junctions are critical facilitators of intercellular signaling 
formed by the interaction of two different cells’ connexons, which are 
hemichannel proteins embedded in the cells’ plasma membranes. These 
connexon hemichannels are each composed of six smaller connexin (Cx) 
protein subunits. Connexin proteins have a short half-life of 
approximately one to three hours, demonstrated from in vitro tissue 
cultures (Solan and Lampe, 2007). This rapid recycling indicates that 
connexin expression is a tightly regulated and adaptable process capable 
of undergoing rapid alterations in response to cellular changes. Connexin 
proteins are synthesized in the rough endoplasmic reticulum (RER), 
passed through the trans-Golgi complex, and finally trafficked via vesicles 
to the plasma membrane. Oligomerization of the six connexin subunits 
into one connexon hemichannel is believed to begin in the ER as the 
protein is synthesized, and end in the Golgi apparatus, where further 
modifications are completed (Lampe and Lau, 2004). 
During this process, the identity of the connexon is established 
through its connexin composition. Twenty different connexin isoforms 
are known to exist in the human genome, classified by their molecular 
weight and their genetic relatedness. Dysfunction and dysregulation of 
connexins has been implicated in a variety of diseases including… (Wei et 
al., 2014). Any of these connexins can be recruited during 
oligomerization to form connexons, giving rise to profound potential for 
diversity among connexons. 
Obstruction of the glial network, and consequential neuronal 
signaling dysfunction, is considered to be a major contributor in the 
accumulation of long-term damage from mTBI (Prochnow et. al, 2014). It 
is likely that gap junctional communication allows for the transmission of 
damage signals produced through the secondary injury of TBI or, 
alternatively, allows for the rapid distribution of these signals throughout 
the glial network to prevent individual afflicted cells from harboring lethal 
levels of these damaging agents. Either way, changes in gap junctional 
communication are likely to play an important role in secondary injury 
from mTBI. 
Due to the vast array of possible connexon conformations, there 
are connexon classifications based on composition. Connexons 
consisting of six identical connexin subunits are called homomeric 
hemichannels, whereas connexons consisting of different connexin 
subunits are called heteromeric hemichannels. Different connexin 
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isoforms have varying abundances in various cell types, suggesting 
functional relevance in their respective cell type (Wei et al., 2004). Further 
contributing to the diverse repertoire of gap junctional communication is 
the composition of the gap junctions themselves. While gap junctions are 
composed of two different connexon hemichannels, they do not have to 
be composed of identical connexons. A gap junction is homotypic if the 
connexon hemichannels contributed by both interacting cells are 
identical, and heterotypic if they are not. The possibility for diversity at 
multiple levels in gap junction formation allows for an abundant resource 
for gap junction communication, and different biological functions 
among differently structured gap junctions. Permeability, weight, 
selectivity for ions and electrical conductance are all factors that diverge 
widely in channels formed by different connexin subunits (Nagy and 
Rash, 2000). 
Connexin-43 (Cx43) is the most widely-expressed connexin in the 
body, having important roles in development and important roles in 
specific tissues and cell types because, unlike many other connexin 
isoforms, it not only is expressed throughout development, but also 
continues to be expressed into adulthood (Dbouk, et al., 2009; Chang 
and Balice-Gordon, 2000). Cx43 is particularly known for its importance 
in astrocytes, one of the four glial cell types found in the brain. 
Astrocytes play a critical role in maintaining homeostasis to support 
healthy neuronal function by encasing regions of axons and whole 
synapses and acting as insulation and protection from the surrounding 
fluctuating ionic environment, allowing for different ionic conditions to 
exist in close proximity and also help maintain stable levels of 
extracellular potassium ions. 
The vast coupling of astrocytes in the brain forms a glial syncytia, 
or network, allowing for uniformity of cytoplasmic composition, rapid 
signaling, and widespread distribution of ions and metabolites. Astrocytic 
elements with gap junctions tend to localize near neuronal structures, 
surrounding synapses, along the unmyelinated Nodes of Ranvier of 
axons, and near glomeruli; these gap junctions universally contain Cx43, 
although the Cx43 concentration in astrocytic gap junctions is not 
uniform and is more localized at points of close interaction between 
astrocytes and neuronal structures (Nagy and Rash, 2000). Most 
connexins are expressed in glial cells, implicating connexins as important 
players in proper maintenance and functioning of the glial network. 
Astrocytes are also important from their role in influencing the blood 
brain barrier (BBB) through the interactions between their end-feet 
projections and the capillaries of the BBB. Astrocytes respond to TBI by 
becoming reactive and undergoing astrogliosis, which ultimately leads to 
formation of a glial scar. Typically, astrocytic projections do not overlap 
with one another; however, reactive astrocytes increase their synthesis of 
glial fibrillary acidic protein (GFAP) – commonly used to stain astrocytes 
Connexin-43 and Traumatic Brain Injury 
 Journal of Undergraduate Research and Creative Activity, Vol. I |  76 
in vitro – and vimentin, two intermediate filaments that help develop the 
cytoskeletal scaffolding needed for the projections to grow and extend 
outward, overlapping with neighboring astrocytes. The consequential 
glial scar formed provides a physical barrier to prevent further interaction 
between injured and healthy neurons, and a chemical barrier due to its 
growth-inhibiting secretions. This has both detrimental and beneficial 
effects. Formation of the glial scar is needed to help maintain and repair 
the integrity of the BBB; however, it prevents neurons from growing and 
regenerating properly. Axon projections attempt to extend only to be 
blocked by the network of overlapping astrocytes that form a 
homogenous barricade via their gap junctional connections. Cx43’s 
interactions with cytoskeletal proteins and subunits affect the scaffolding 
and shape of the cell, as changes in cell shape have been observed 
following mTBI. In regard to cell arrangement, a monolayer of cells has 
been demonstrated to be more effective for neuroprotection and better 
for cell survival. 
Currently, there is no effective therapeutic intervention available to 
allay the secondary injury associated with TBI. Current research seeks to 
understand the events involved in propagating this damage in hopes of 
finding a point in the cytotoxic cascade to target and interrupt the 
accumulation of damage. Many important facets of secondary injury have 
been described, but scarce research has been conducted on the role of 
gap junctional coupling in transmitting these damaging signals, given its 
apparent importance. There is a need for understanding the role of 
connexin components in the gap junctional communication associated 
with TBI; particularly, connexin-specific regulators need to be identified 
and connexin-specific contributions to TBI must be established. 
Additionally, the relative abundance of the different connexin isoforms in 
different regions of the brain must be quantified definitively and mapped 
out and relative biological function of each connexin isoform established, 
including the nature and consequences of Cx43’s interactions with 
myriad proteins. 
Among the research conducted on this topic, various studies have 
reported a damaging effect of Cx43-gap junctions through its spread of 
damage signals to otherwise healthy neighboring cells in the glial 
syncytium (Frantseva et al., 2002). Moreover, Cx43 deletion in astrocytes 
of mouse brain resulted in milder injury and less ATP release from 
damaged cells, a significant factor in secondary injury accumulation, 
indicating that Cx43 presence begets cellular damage. Tissues bordering 
spinal cord injury (SCI) sites demonstrated upregulated Cx43 (Huang, 
2012). Notably, Cx43-knockout mice exhibited less severe reactive 
astrogliosis following TBI and failed to develop Cx43 plaques like their 
wild-type counterparts. This study concluded that gap junctions 
destructively spread damage signals following trauma (Huang et. al, 
2012). Cx43-gap junctional channels are exceptionally permeable to ATP, 
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ADP, and AMP (Lampe & Lau, 2004), making them potential regulators of 
changes in cellular metabolism following injury. 
Other studies have reported contrasting results supporting the 
neuroprotective roles of such channels. One study concluded that 
reactive astrogliosis was a neuroprotective process from their findings 
that ablation of reactive astrocytes following controlled cortical impact 
(CCI) trauma exacerbated injury, suggesting that its net effect was 
protective in mTBI through limiting inflammation and preventing damage 
to neural tissue. Interestingly, there was no net effect observed following 
severe trauma, indicating that there is a threshold for the usefulness of 
this possibly neuroprotective process (Myer et al., 2006). 
Regardless of their contradictory findings, these studies tend to 
agree that gap junctional coupling has an elusive, yet seemingly critical 
role in attenuating or exacerbating neuronal apoptosis following mTBI 
due to an apparent, transient increase in gap junctional coupling 
following TBI (Frantseva et al., 2002). The notable correlation between 
changes in the phosphorylation of Cx43 and changes in gap junctional 
communication suggest that Cx43 has particular importance in the post-
TBI gap junctional communication processes, and also makes sense due 
to its high permeability for ATP, ADP, and AMP. Phosphorylation mediates 
Cx43 after trauma, and Cx43 throughout normal brain tissue is 
overwhelmingly phosphorylated. Dephosphorylated Cx43 causes changes 
in gap junctional intercellular communication (GJIC) and reported changes 
in the conduction of the gap junction channel that may all be caused by 
increased neural activity. Given that over 90% of homologous astrocytic 
gap junctions contain Cx43 on both faces of the connection (Nagy & 
Rash, 2000), it is possible that homotypic Cx43-composed gap junctions 
are responsible for the patterns observed in gap junctional 
communication post-TBI, as an increase in levels of Cx43 is observed, 
accompanied by a structural modification that changes exposed epitopes. 
However, this change is not observed in cases of severe trauma and 
extensive neuronal damage; paradoxically, the Cx43 levels are actually 
decreased in these regions of severe damage. There is a need for 
understanding the relative levels of Cx43 and phosphorylated-Cx43 
expressed in normal tissue and traumatized tissue, identifying specific 
channel blockers, and identifying the nature of the damage signals 
spread throughout the glial syncytium - IP3 a suggested candidate due to 
its alleged involvement in cell death as well as the increase in IP3- 
mediated signaling post-TBI (Frantseva et al., 2002). 
Cx43 has the secondary classification of gap junction alpha-1 (Gja-
1), also the name of the gene that encodes the Cx43 protein. Gja-1 refers 
to the similarities of Cx43 with other Cx protein sequences, and also 
indicates that Cx43 was the first alpha Cx discovered, explaining why it 
has the number one. Cx43 is known to have a short half- life, allowing for 
its expression to be tightly regulated and rapidly altered (Dbouk, et al., 
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2009 and Lampe and Lau, 2004). Cx43 is a potential key player in 
secondary injury post- TBI, although its role is evidently unclear and 
highly debated due to its contradictory neuroprotective and also 
neurotoxic effects. Knockout mice have been used in multiple studies to 
assess the relationship between Cx43 and the extent of neuronal cell 
death. 
GFAP-positive astrocytes were found to be more abundant in 
Cx43+/+ mice than Cx43+/- mice (Ohsumi, A. et al, 2000). These 
findings indicate that a deficit in Cx43 expression could possibly disrupt 
the accumulation of GFAP and somehow dampen reactive gliosis. 
Furthermore, the extent of neuronal cell damage was significantly 
reduced in Cx43 knockout mice (Franseva et al., 2002). The present study 
hypothesizes that the presence of Cx43 in secondary injury processes 
occurs early on in reactive astrocytes and is a precursor for the changes 
observed in cellular metabolites and interactions seen later in secondary 
injury. Since Cx43 directly associates with intermediate filament proteins, 
and has been shown to undergo phosphorylation changes post-TBI that 
ultimately have some effect on gap junctional communication (GJC) in the 
glial syncytium, it is likely that the structural changes and consequential 
functional changes that occur and rearrange Cx43’s exposed epitopes 
allow for the upregulation of GFAP and vimentin proteins and 
consequentially usher in astrogliosis. Due to the relationship between the 
phosphorylation of Cx43 and its structural changes, as well as Cx43’s 
interaction with intermediate filament proteins involved in astrogliosis, it 
is possible that changes in Cx43 phosphorylation states lead to the 
structural changes that occur in intermediate filaments of reactive 
astrocytes. Given the Catch-22 effects of glial scar formation and reactive 
astrocytes, it makes sense that changes in Cx43 would produce 
contradictory neuroprotective and neurotoxic effects experimentally. 
The relative levels of Cx43 phosphorylation have been shown to 
have significant correlation with injury processes. Phosphorylation of 
Cx43 is conferred by the extracellular-signal regulated kinase (ERK) 
pathway, and this causes a significant reduction in the permeability of 
these gap junctions (Ohsumi, A, et al., 2010; Prochnow, N., 2011). Given 
that a relationship exists between the phosphorylated state of Cx43 (p- 
Cx43), the permeability of certain gap junctions, and post-injury 
processes, it seems that Cx43 is a key player in secondary injury. 
Moreover, experimentally induced expression of Cx43 provides 
neuroprotection, but apparently not through gap junctional 
communication, as this affect is still observed in the presence of gap 
junctional blockers (Butkevich, et al., 2004). Levels of p-Cx43 are in flux, 
with varying levels observable at different times post-injury and an 
apparent peak of p-Cx43 levels at approximately six hours post-injury 
(Ohsumi, et al., 2010). Astrocytes of the hippocampus demonstrated an 
increase in p-Cx43 following mTBI, which induced ERK-regulated 
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phosphorylation and led to an increase in Cx43 expression in these cells 
apparently facilitating GJC among astrocytes of the hippocampus (Ohsumi 
et al., 2004). Because the hippocampus is the region of the brain 
primarily responsible for formation and storage of memories, damage to 
the hippocampus results in learning and memory deficits. It seems that 
Cx43 expression following mTBI is highly conditional upon the cellular 
and environmental factors the cell is experiencing, demonstrating a 
dependency on time, location and the state of neighboring cell types. It 
may be that hemichannels composed of Cx43, as well as the gap 
junctional coupling that occurs among them, have both damaging and 
neuroprotective effects post-injury that dominate at different times and in 
different circumstances. 
The debate over whether reactive astrocytes are damaging or 
neuroprotective is an argument between the “Good Samaritan” and the 
“Bystander Effect” hypotheses. There is neuronal cell loss observed after 
TBI, and also glial cell loss, including astrocytes; however, viable glial 
cells respond to this damage by overcompensating, leading to reactive 
gliosis. Cx43 is the connexin isoform most strongly associated with 
astrocytes and, in traumatized astrocytes, may allow for propagation of 
the harmful biochemical and messengers that lead to further secondary 
tissue damage in what is commonly referred to as the ‘Bystander Effect,’ 
‘kiss-of-death,’ or cellular ‘fratricide.’ Cx43-composed gap junctions of 
astrocytes cause an observable increase in calcium overload, oxidative 
stress, and metabolic dysfunction (Ohsumi et al., 2004). Alternative to 
this destructive, damage- signal-propagation effect is the idea of the 
‘Good Samaritan,’ a neuroprotective strategy possibly employed by the 
glial network in the spirit of ‘share-the-load,’ to prevent individually 
damaged cells from reaching a critical load of harmful cytotoxins by 
distributing these agents among otherwise healthy neighboring cells to 
prevent any one cell from becoming overwhelmed. The neuroprotective 
effect is supported by the contrasting observation of astrocytic Cx43-gap 
junctions as scavengers of damaging cytotoxic agents (Ohsumi et al., 
2004). It is possible that the reactive astrocytes are both Good Samaritans 
and Bystander Killers at different points in the secondary injury process. 
The present study investigates the role of Cx43 in the secondary 
incidence of mTBI to reveal a potential correlation between Cx43 
expression and the biochemical events responsible for the secondary 
injury associated with mTBI in order to shed light on the role of this 
specific protein subunit and its importance as a therapeutic target. 
Supported by the work of Franseva, et al., which calls for connexin-
specific assessment of impact on neuronal cell death possible through 
the use of specific anti- connexin antibodies, the present study assesses 
the extent of fluctuation in Cx43 expression in response to different 
treatments in astrocyte cell culture. Moreover, Frantseva, et al. maintain 
that the levels of Cx43 synthesized and expressed in normal subjects is 
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unestablished, identifying a need for this knowledge. The present study 
seeks to somewhat address this gap in knowledge via comparative 
analysis of Cx43 expression in normal hippocampal tissue samples from 
a Wistar rat (sham), Wistar rats subjected to moderate TBI and treated 
with saline (control), and Wistar rats subjected to moderate TBI and 
treated with gamma-glutamylcysteine ethyl ester (GCEE), an antioxidant. 
GCEE is an important antioxidant due to its ability to increase production 
of glutathione (GSH), which is the most prominent antioxidant in the body 
and helps to combat oxidative stress and reduce reactive oxygen species 
(ROS) that are largely responsible for oxidative stress. The structure of 
GCEE is depicted in Figure 16 and the structure of GSH is depicted in 
Figure 18. Comparative analysis will be conducted through quantification 
of Cx43 expression in the hippocampus through RNA extraction, reverse 
transcription, and subsequent qPCR analysis of twenty different 
hippocampal rat brain samples from three different experimental 
populations: sham, TBI + saline, and TBI + GCEE. 
 
MATERIALS & METHODS 
 
Expression levels for Cx43 in different regions of the hippocampus 
are quantified in the present through methods of RNA extraction, reverse 
transcription, and real-time PCR (qPCR), and treatments on cultured 
astrocytes alongside immunohistochemistry. RNA kit, and primers for 
qPCR were all purchased from Life Technologies (Carlsbad, CA). 
 
RNA Extraction Protocol: 
• 100mg per sample were individually weighed from brain tissue 
samples stored in the -80ºC and transferred on ice to separate 
1.5mL tubes containing approximately 1mL each of RNAlater 
reagent (Life technologies, Carlsbad, CA) and stored for 
approximately 30 minutes. 
• Brain tissue was removed from 1.5mL tubes and transferred to 
individual Lysing Matrix D tubes containing 1mL each of Trizol. 
• The tissue was lysed in a FastPrep-24 machine (NP Biomedicals, 
Newport, CA) for six cycles at 45 seconds per cycle. In order to 
prevent degradation of the tissue from excessive heating, 
samples were iced for one minute between each cycle. 
• The sample mixture was then pipetted from the Lysing matrix D 
tubes, without transferring any beads from the Lysing Matrix D 
tubes, to new 1.5mL tubes, which were subsequently shaken in 
an incubator at room temperature for approximately five 
minutes. 
• Tubes were centrifuged at 12,000 x g at 4ºC for ten minutes to 
separate the layers 
• Liquid-liquid extraction was performed, pipetting the upper 
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aqueous layer, without any material from the lower layer, into a 
new 1.5mL tube for each sample. 
• Approximately 200µL of chloroform was added and 
subsequently shaken for fifteen seconds by hand, then 
incubated for 2-3 minutes at room temperature. 
• Tubes were centrifuged again at 12,000 x g at 4ºC for fifteen 
minutes, and the upper aqueous layer was transferred into a 
new tube, avoiding the transfer of any material from the lower 
layers. 
• Approximately 300µL of cold isopropanol (stored at 
approximately -20ºC for at least twenty minutes) was then 
added to each tube and inverted five times by hand and 
subsequently stored for thirty minutes at -20ºC. 
• Tubes were again centrifuged at 12,000 x g at 4ºC for 
approximately ten minutes, and supernatant was pipetted off 
and discarded, leaving pellets which were subsequently washed 
with approximately 1mL of cold 75% ethanol (mixed one mL 
nuclease-free water for every three mL absolute ethanol). 
• Small, white pellets were then vortexed back into solution and 
subsequently centrifuged at 7,500 x g at 4ºC for ten minutes. 
• Ethanol was pipetted off and discarded and the pellet was 
subsequently air dried at room temperature for five minutes, 
although pellets were monitored to avoid complete desiccation. 
• Pellet was then resuspended in 100µL of nuclease-free water 
and stored in the - 80ºC freezer for future use 
 
NanoDrop Protocol: 
• RNA samples were retrieved from the -80ºC freezer and thawed 
on ice to prevent degradation of RNA. 
• Once thawed, RNA samples were analyzed using a NanoDrop 
spectrophotometer (Thermo Scientific, Waltham, MA). The 
NanoDrop’s sensor was first cleaned by running a blank sample 
of nuclease-free water. 
• Each sample was briefly vortexed before a drop was pipetted 
onto the NanoDrop’s sensor, and analysis was run using the 
NanoDrop’s software technology; the Nanodrop sensor was 
cleaned by wiping with a KimWipe between each sample run. 
• NanoDrop analyses of all RNA samples’ concentration was 
compiled (ng/µL) and purity was assessed (260/280 abs). A 
spreadsheet of these results was produced and checked to make 
sure samples were pure by looking at the 260/280 abs. A 
260/280 sample readout with a ratio of two or less indicates a 
purer sample. 
• RNA samples were returned to the -80ºC freezer after use and 
stored for later analysis. 
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Gel Protocol: 
• FlashGel™ System (Lonza Rockland, Inc., Rockland ME) for RNA 
separation and analysis was used to verify the presence of RNA 
and not DNA, since the NanoDrop cannot make this distinction. 
The Flashgel™ System detects RNA quantities <10ng per band. 
• RNA samples were removed from the -80ºC freezer and thawed 
on ice to prevent degradation from heat. 
• Once thawed, each RNA sample was prepared in a separate tube 
with FlashGel™ Loading Dye (Lonza Rockland, Inc., Rockland ME 
04841) so that each tube contained a 5µL load with a 
concentration of less than or equal to 200ng of RNA per band; 
for these wells, 2µL RNA were mixed by pipetting with 3µL 
Loading Dye. These prepared loads were stored on ice until 
ready for gel loading. 
• Flashgel™ RNA Cassette was opened and flooded with nuclease-
free water using a pipette. Water was subsequently absorbed 
with a KimWipe by tilting the cassette and allowing the water to 
drain out of the corner. Wells were not directly blotted or 
handled. 
• Flashgel™ RNA Cassette was loaded onto dock as shown in 
Figure 5. Dock was subsequently connected to power supply 
with red and black cables. 
• Once connected, power supply was turned on and voltage was 
set to 225mV. Top was snapped on to dock as shown in Figure 
6, and gel was run for at least eight minutes without 
interruption. 
• After eight minutes, voltage was turned off and leads were 
disconnected from power supply to remove cassette. 
• Gel was then allowed to sit for approximately ten minutes and 
subsequently exposed and photographed, as shown in Figure 7. 
• RNA was returned to the -80ºC freezer for storage until further 
use. 
 
Reverse Transcription Reaction Protocol: 
• RNA was removed from the -80ºC freezer and thawed on ice to 
prevent degradation. 
• Reverse Transcription is used to convert the RNA samples into 
cDNA and was performed using a high-capacity cDNA kit 
(Applied Biosystems, Foster City, CA, Part No. 4368814); cDNA 
kit components were thawed on ice until ready for use. 
• 2X RT Master Mix was prepared on ice, first by calculating the 
volume of each kit component needed for the required number 
of reactions, plus 10% of that number to account for any errors 
or spills during transfer. Calculations were done for 31 samples, 
so component volumes needed were calculated for 34.1 samples 
Connexin-43 and Traumatic Brain Injury 
 Journal of Undergraduate Research and Creative Activity, Vol. I |  83 
in order to provide enough excess in case of error, based on 
initial sample size. Calculations were based by multiplying the 
sample number by the volumes listed in Table 1. 
• The 2X Master Mix was mixed in a 1.5mL tube on ice then 
mixed gently via pipette 
• 10µL 2X master mix was then pipetted into 31 individually, 
labeled 0.2mL PCR tubes for each reaction 
• 10µL RNA sample was subsequently pipetted into corresponding 
tube and pipetted up and down two times gently to mix. Tubes 
were then sealed. 
• 2mL tubes with their caps cut off were used as nests for 
centrifugation. The 0.2mL reaction tubes were place in the 2mL 
nested tubes centrifuge and centrifuged for approximately 15 
seconds on pulse in order to eliminate any possible air bubbles. 
• Tubes were placed on ice until ready for loading into the 
thermal cycler 
• Thermal cycler was programmed according to Table 4, which is 
also depicted in Figure 8. 
 
PCR Protocol: 
• Real-Time PCR (qPCR) analyzes relative mRNA concentrations of 
target genes expressed in samples, reflecting expression levels 
of target genes. To run the reaction, Universal Master Mix 
(Applied Biosystems, Carlsbad, CA) is used, which includes 
Taqman primers and probes, as well as PCR reagents. The cDNA 
made by reverse transcription of extracted mRNA is used to run 
the reaction. 
• Subsequently, reaction is run with both experimental assay gap 
junction alpha-1 (Gja1, 87 amplicon length, Life Technologies, 
Carlsbad, CA) as well as a control, glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh, 174 amplicon length, Life Technologies, 
Carlsbad, CA), which should be equally expressed across all 
cells since it is a “housekeeping gene” responsible for standard 
cellular metabolism events. Half of the prepared reaction plate is 
experimental and half the prepared reaction plate is control, 
with each sample run twice (once on each side of the reaction 
plate) 
• 1µL of 20X TaqMan gene expression assay solution, 10µL 2X 
gene expression master mix, and 8µL nuclease-free water were 
used per reaction well. Before beginning, the amount of each 
reagent needed was calculated based on the desired number of 
reactions and these volumes were subsequently mixed in two 
different reaction tubes, using Gapdh as the assay reagent for 
one of the tubes, and Gja1 for the other. 
• Gja1 assay solution was used as the experimental assay, and 
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glyceraldehyde-3- phosphate dehydrogenase was used as a 
control. 
• Assays were mixed by pipetting up and down twice and then 
vortexed briefly. 
• 1µL cDNA sample was subsequently added to each designated 
well and a standard TaqMan PCR program was immediately 
performed. 
• The ∆∆CT is run with desired number of well plates, “TaqMan 
reagents” and “standard” (2 hour) time. 
• Plate layout must be assigned with “Plate set-up,” then “define 
targets and samples.” Samples are defined by highlighting wells 
and assigning them with either Gapdh control or with Gja1 
experimental. 
• The plate is lined up to reflect the plate layout already assigned, 
and then the run is started. The PCR reaction takes 
approximately two hours per reaction plate. 
 
Astrocyte Cell Culture Protocol: 
Astrocytes were stored in liquid nitrogen tank until ready for use to 
preserve viability (Invitrogen, Carlsbad, CA). Astrocytes were thawed in a 
37º water bath for two minutes, swirling vial occasionally to ensure 
complete melting of ice. All live cell culture work was done under a flow 
hood to prevent contamination. UV-light in hood was turned on prior to 
beginning and allowed to warm-up. Astrocytic media was prepared (85% 
DMEM + 15% FBS) by removing 88.5mL DMEM from a 500mL DMEM bottle 
and replacing it with 88.5mL FBS (Invitrogen, Carlsbad, CA). Under the 
flow hood, the astrocytes were transferred from their vial to a new 15mL 
tube. The vial was then rinsed with 1mL of the prepared medium, 
dropwise, and this solution was subsequently added to the 15mL tube, 
making a total volume of 2mL of cells. 8mL of complete medium were 
then added to the tube to make a total of 10mL in the tube. This tube 
was centrifuged for five minutes at 250 x g and then the supernatant was 
decanted under the flow hood. 2mL medium were added to this 15mL 
tube and the astrocytes were resuspended by pipetting up and down. 
This solution was then pipetted onto a plate in a circular pattern, to 
ensure distribution of the cells and spread them out across the plate. 
Plated cells were observed under a microscope in order to ensure that 
they were spread evenly and not crowding each other. The plate 
containing the cells was then incubated at 37ºC, 5% CO2, 90% humidity. 
Media was replaced approximately every 4 -5 days and a cell viability 
(MTT) assay was done to test for cell stress. Four different populations of 
astrocytes were compared: normal/untreated, treatment to reduce Cx43 
expression (octanol) (Pekny and Nilsson, 2005), hydrogen peroxide 
(H2O2) treatment to induce oxidative stress, and antioxidant treatment 
(750 uM GCEE). The effects of Cx43 on neuronal damage was 
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subsequently assessed through DCF and MTT assays (relative oxidative 
stress levels and cell viability, respectively) of all four astrocytic 
populations. 
 
RESULTS 
 
RNA extraction was performed on five separate occasions, as listed 
in Table 2. Extractions were among hippocampal samples with different 
treatments at different time points including sham, TBI + saline at 30 
minutes, TBI + saline at 60 minutes, TBI + GCEE at 30 minutes, and TBI + 
GCEE at 60 minutes. The samples are listed according to treatment 
classification in Table 3. NanoDrop results indicated RNA samples 
extracted were pure and of good quality, having a 260/280 abs of 
approximately less than or equal to two, as depicted in Figure 1. All three 
FlashGels™ run indicated that uncontaminated RNA was present in all 
samples extracted, as shown in Figures 2, 3 and 4. 
Extracted mRNA was successfully converted to cDNA through 
reverse transcription and subsequently analyzed through qPCR. In order 
to conserve use of resources, only twenty samples were run: six sham, 
six TBI + GCEE at 30, and eight TBI + saline at 30. Samples used are listed 
in Figures 13 and 14. Two qPCR plates were run and their corresponding 
amplification plots are depicted in Figures 9 and 10. A schematic of the 
two plates’ set-up and the samples run can be seen in Figures 13 and 14. 
Fold-change calculations were done to determine the normalized gene 
expression of Gja1 amongst the three different treatment populations. 
Expression in the sham population was set to one, as a standard for 
comparison. The fold change of the saline-treated samples was 1.412 
compared to the sham control. The fold change of the GCEE-treated 
samples was 0.903 compared to the sham control. A single-sided ANOVA 
statistical analysis was performed with the ΔCT values of the qPCR for 
each treatment, and is depicted in Figure 12. A single-sided ANOVA was 
practical for statistical analysis of these results because it compares 
variation with in situations where there are more than two treatment 
types, or populations. A single-sided ANOVA compares the variation 
between samples of one treatment type to the variation between the 
differences observed in the different treatment types and indicates 
whether or not there is a significant change observed between different 
treatment types relative to the variation between samples in one 
treatment type. Despite the trend observed, the results of the ANOVA 
indicated that this trend was not statistically significant. 
Cell culture work was delayed because the cells died during a 13-
day period of heavy snow that made the cells inaccessible and therefore 
media could not be replaced. This experiment is a future direction and 
will completed during the spring and summer 2015. 
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CONCLUSIONS/DISCUSSION 
 
Despite the lack of statistical significance from the results of the 
qPCR research, a noteworthy trend does exist that should be investigated 
further, and the implications of such a trend are discussed here. 
Normalized fold-change of gene expression for GJA1 demonstrated an 
increase from sham levels in the mTBI with administered saline 30 
minutes post-injury. However, this increased level of GJA-1 expression 
returned back to below sham levels for the mTBI with administered GCEE 
30 minutes post-injury. If this trend is reflective of a statistically 
significant phenomena, these results would indicate that the expression 
of GJA-1, and consequentially the amount of Cx43 protein translated, 
correlates with oxidative stress. The mTBI with saline model indicates 
that there is more Cx43 protein translated when oxidative stress is 
introduced. With the addition of the GCEE antioxidant, which substantially 
relieves oxidative stress, there could be less of a need for Cx43, causing 
GJA1 to be less expressed. These observations would likely support the 
‘Good Samaritan’ view of Cx43’s role, as this oxidative-stress-dependent 
presence would likely be compensatory. The increased expression of 
GJA1 in the mTBI with saline treatment could support either the ‘Good 
Samaritan’ or ‘Bystander Effect’ contentions, but the decrease in GJA1 
expression observed after administering antioxidant more likely lends 
itself to the ‘Good Samaritan’ hypothesis. A possible explanation for this 
phenomenon is the synthesis of the most prominent natural antioxidant 
employed by the body to combat oxidative stress: glutathione (GSH). GSH 
is composed of three amino acids, glutamate, glycine and cysteine. 
Because of the significantly lower concentration of cysteine in the brain 
as compared to glycine and glutamate, cysteine is the limiting factor for 
GSH synthesis (Drake, et al., 2002). GSH is available at greater levels in 
astrocytes than in neurons, and is the most pronounced way that 
astrocytes are able to protect neurons from oxidative stress. For co-
cultured systems containing both neurons and astrocytes, the neurons 
were more susceptible to damage from oxidative stress if the astrocytes’ 
gap junctional communication was inhibited (Sáez, 2003). Astrocytic 
protection of neurons is crippled when GSH levels are decreased in the 
astrocytes, but when GSH is available astrocytes are able to protect 
approximately twenty neurons per astrocyte against damage from 
oxidative stress, particularly from the reactive oxidative species , 
hydrogen peroxide (Dringen, et al., 2000). GSH synthesis requires an 
interplay between astrocytes and neurons. Cysteine availability limits GSH 
production in neurons alone and determines their GSH levels. However, 
when astrocytes are present, GSH levels increase in neurons, meaning 
that astrocytes provide and essential cysteine- precursor that the neurons 
are then able to use to fuel GSH production to combat oxidative stress. 
This nature of this precursor has been experimentally identified as CysGly 
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(Dringen et al., 2000). Because glutamine is released from astrocytes, and 
CysGly is produced extracellularly through the action of an astrocytic 
ectoenzyme, that reacts with GSH so that these components can be 
uptaken by neurons and subsequently used to produce GSH within the 
neurons, astrocytes furnish all three necessary ingredients for GSH 
production to neurons (Dringen, et al., 2000). This interaction is depicted 
in Figure 15. If the trend observed in the RNA work of this study is 
statistically significant, it could be explained by this phenomenon, as the 
Cx43 increase observed from TBI would aid diffusion of GSH, glutamine, 
and ATP out of the astrocyte at a greater rate through Cx43 
hemichannels, allowing for the raw materials for GSH synthesis to be 
uptaken by the neurons. The decrease in Cx43 expression in the TBI with 
GCEE treatment administered that may be reflective of a significant trend 
would also make sense when considered in this context, because GCEE 
would provide the raw materials needed for neuronal uptake to fuel GSH 
production, bypassing the need for an increase in Cx43 hemichannels in 
astrocytes since the diffusion of these reactants out of astrocytes would 
be unnecessary since the reactants would already be provided by the 
GCEE. 
The metabolism of glutathione is depicted in Figure 17. GSH 
synthesis requires ATP for two different steps, making ATP a limiting 
factor as well depending on the antioxidant demands of the brain. In a 
time of injury, when oxidative stress poses a serious threat to the health 
of the brain, GSH production increases in order to help preserve the 
brain’s tissues and functioning. Studies have demonstrated that a major 
component of the release of ATP from astrocytes that occurs following 
injury is through opening of Cx43 hemichannels because ATP can diffuse 
through Cx43 hemichannels and Cx43-composed gap junctions (Huang, 
et al., 2012). In this way, a plausible trend for GJA1 upregulation could be 
reflective of the brain’s attempt at self-preservation by increasing the 
amount of Cx43 so that Cx43 hemichannels or gap junctions can be 
constructed to allow for the more rapid and widespread distribution of 
ATP throughout astrocytes as well as increased ability for astrocytes to 
provide the necessary reactants to neurons to facilitate neuronal 
production of GSH and prevent neuronal damage from oxidative stress. 
Cx43 hemichannels do not preferentially allow the passage of GSH, but 
would help increase the rate of GSH synthesis in neurons by providing the 
raw reactant needed. Additionally, the increased ATP release through 
Cx43 gap junctions and hemichannels affects the formation of astrocytic 
stress fibers, as well as the morphological changes that occur post-
trauma, like cellular flattening (Lin, et al., 2003), which helps facilitate 
reactive astrogliosis processes. 
Aside from facilitating passage of signaling molecules, secondary 
messengers, ATP, and ions, gap junctions also allow for the exchange of 
small interfering RNA (siRNA) between cells (Dbouk, et al., 2009), which 
Connexin-43 and Traumatic Brain Injury 
 Journal of Undergraduate Research and Creative Activity, Vol. I |  88 
could allow it to regulate gene expression for certain proteins. Moreover, 
Cx43 has been postulated as a regulator of gene expression through 
recruitment of transcription factors (Giepmans,B. N G., 2004). Therefore, 
the effects of Cx43 on gene expression of both protective and damaging 
factors should be investigated further. 
In the future, this research should be re-done with a greater sample 
size per treatment type in order to determine whether or not the 
observed trend is statistically significant. Moreover, it would be helpful to 
investigate any possible relationship between p-Cx43 and treatment type. 
Phosphorylation is a means of Cx43 regulation (Lampe and Lau, 2004) 
and p-Cx43 is mostly concentrated in brain tissue six-hours post injury 
(Ohsumi, et al., 2010), indicating that the phosphorylation state of Cx43 
plays a role in post-traumatic processes, and it would be interesting to 
investigate whether or not reducing Cx43 expression or administering an 
antioxidant (i.e. GCEE) would have any effect on the ratio of 
unphosphorylated-Cx43 and p-Cx43. Another future direction of this 
research would be to assess the possible structural changes of the 
astrocyte projections resulting from intermediate filament activity under 
different treatment conditions, and observe any potential influence of 
Cx43 on intermediate filament behavior or morphology to ultimately 
assess if Cx43 plays a role in the morphological changes of astrocytes 
during reactive astrogliosis that lead to glial scar formation and plaques. 
Astrocytes upregulate their intermediate filament production following 
trauma, facilitating the process of reactive astrogliosis and have been a 
strong reason some researchers consider astrocytes to be predominantly 
protective following injury (Pekny and Nilsson, 2005; Dbouk et al., 2009). 
Moreover, mice with a predisposition to lower levels of Cx43 expression 
were demonstrated to have less rapid upregulation of GFAP following 
trauma, slowing the process of reactive astrogliosis (Ohsumi, et al. 2010). 
Additionally, drebrin (developmentally-regulated brain protein) – a 
protein that binds to actin, an important intermediate filament - is a 
newly-recognized binding partner of Cx43’s carboxy-terminal tail and has 
been implicated as a key player for maintenance of gap junctional 
communication, responding to changes in cellular signaling, drebrin- 
deficient astrocytes had lower levels of p-Cx43 and caused a decline in 
the permeability of gap junctions (Butkevich, et al., 2004). Because Cx43 
has direct interactions with multiple intermediate filaments, which is 
related to the phosphorylation state of Cx43, it would be good to 
research this relationship’s response to different treatment types 
including one that induces oxidative stress (i.e. H2O2) and one that 
reduces Cx43 expression (i.e. octanol). 
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